Research & Literature

Diagnosing and treating neurogenic orthostatic hypotension in primary care.

Kuritzky L, Espay AJ, Gelblum J, et al.

Postgraduate medicine 2015; (127(7)):702-15 doi:10.1080/00325481.2015.1050340.

Natural history of multiple system atrophy in the USA: a prospective cohort study.

Low PA, Reich SG, Jankovic J, et al.

The Lancet. Neurology 2015; (14(7)):710-9.

An update on the cerebellar subtype of multiple system atrophy.

Ciolli L, Krismer F, Nicoletti F, Wenning GK

Cerebellum & ataxias 2014; (1()):14 doi:10.1186/s40673-014-0014-7.

Survival in synucleinopathies: A prospective cohort study.

Goldstein DS, Holmes C, Sharabi Y, Wu T

Neurology 2015; (85(18)):1554-61 doi:10.1212/WNL.0000000000002086.

Managed care approach to the treatment of neurogenic orthostatic hypotension.

Isaacson SH

The American journal of managed care 2015; (21(13 Suppl)):s258-68.

Laryngeal stridor in multiple system atrophy: Clinicopathological features and causal hypotheses.

Ozawa T, Sekiya K, Aizawa N, et al.

Journal of the neurological sciences 2016; (361()):243-9.

Expanding concept of clinical conditions and symptoms in multiple system atrophy.

Watanabe H, Riku Y, Nakamura T, et al.

Rinsho shinkeigaku = Clinical neurology 2016; (56(7)):457-64 doi:10.5692/clinicalneurol.cn-000903.

Progression of alpha-synuclein pathology in multiple system atrophy of the cerebellar type.

Brettschneider J, Irwin DJ, Boluda S, et al.

Neuropathology and applied neurobiology 2017; (43(4)):315-329 doi:10.1111/nan.12362.

Does the Type of Multisystem Atrophy, Parkinsonism, or Cerebellar Ataxia Impact on the Nature of Sleep Disorders?

Ferini-Strambi L, Marelli S, Combi R

Current neurology and neuroscience reports 2016; (16(12)):105 doi:10.1007/s11910-016-0704-z.

Palliative Care Discussions in Multiple System Atrophy: A Retrospective Review.

Dayal AM, Jenkins ME, Jog MS, et al.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2017; (44(3)):276-282 doi:10.1017/cjn.2016.439.

α-Synuclein: Multiple System Atrophy Prions.

Woerman AL, Watts JC, Aoyagi A, et al.

Cold Spring Harbor perspectives in medicine 2018; (8(7)) doi:10.1101/cshperspect.a024588.

Palliative care and its emerging role in Multiple System Atrophy and Progressive Supranuclear Palsy.

Wiblin L, Lee M, Burn D

Parkinsonism & related disorders 2017; (34()):7-14 doi:10.1016/j.parkreldis.2016.10.013.

Degeneration of rapid eye movement sleep circuitry underlies rapid eye movement sleep behavior disorder.

McKenna D, Peever J

Movement disorders : official journal of the Movement Disorder Society 2017; (32(5)):636-644 doi:10.1002/mds.27003.

Multiple system atrophy: clinicopathological characteristics in Japanese patients.

Ozawa T, Onodera O

Proceedings of the Japan Academy. Series B, Physical and biological sciences 2017; (93(5)):251-258 doi:10.2183/pjab.93.016.

REM Sleep Behavior Disorder in Parkinson's Disease and Other Synucleinopathies.

St Louis EK, Boeve AR, Boeve BF

Movement disorders : official journal of the Movement Disorder Society 2017; (32(5)):645-658 doi:10.1002/mds.27018.

Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy.

Koga S, Dickson DW

Journal of neurology, neurosurgery, and psychiatry 2018; (89(2)):175-184 doi:10.1136/jnnp-2017-315813.

Potential clinical utility of multiple system atrophy biomarkers.

Jellinger KA

Expert review of neurotherapeutics 2017; (17(12)):1189-1208 doi:10.1080/14737175.2017.1392239.

Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms.

Eschlböck S, Wenning G, Fanciulli A

Journal of neural transmission (Vienna, Austria : 1996) 2017; (124(12)):1567-1605 doi:10.1007/s00702-017-1791-y.

REM Sleep Behavior Disorder: Diagnosis, Clinical Implications, and Future Directions.

St Louis EK, Boeve BF

Mayo Clinic proceedings 2017; (92(11)):1723-1736 doi:10.1016/j.mayocp.2017.09.007.

Multiple system atrophy: Building a global community - 30years of advocacy efforts.

Bower PG

Autonomic neuroscience : basic & clinical 2018; (211()):39-42 doi:10.1016/j.autneu.2017.12.006.

[Self-intermittent-catheterization and urinary retentions in Parkinsonian syndromes].

Savard E, Declemy A, Coindreau V, et al.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 2018; (28(17)):987-992 doi:10.1016/j.purol.2017.11.004.

Causes of Death in Chinese Patients with Multiple System Atrophy.

Zhang L, Cao B, Zou Y, et al.

Aging and disease 2018; (9(1)):102-108 doi:10.14336/AD.2017.0711.

Patterns of dopamine transporter imaging in subtypes of multiple system atrophy.

Bu LL, Liu FT, Jiang CF, et al.

Acta neurologica Scandinavica 2018; (138(2)):170-176 doi:10.1111/ane.12932.

Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies.

Peng C, Gathagan RJ, Covell DJ, et al.

Nature 2018; (557(7706)):558-563 doi:10.1038/s41586-018-0104-4.

Prospective study of relevance of 123I-MIBG myocardial scintigraphy and clonidine GH test to distinguish Parkinson's disease and multiple system atrophy.

Alves Do Rego C, Namer IJ, Marcel C, et al.

Journal of neurology 2018; (265(9)):2033-2039 doi:10.1007/s00415-018-8941-5.

Bladder dysfunction as the initial presentation of multiple system atrophy: a prospective cohort study.

Sakakibara R, Panicker J, Simeoni S, et al.

Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2019; (29(6)):627-631 doi:10.1007/s10286-018-0550-y.

Prevalence of pain in atypical parkinsonism: a systematic review and meta-analysis.

Rana AQ, Qureshi AR, Siddiqui O, et al.

Journal of neurology 2019; (266(9)):2093-2102 doi:10.1007/s00415-018-9049-7.

Clinical characteristics and quality of life in Chinese patients with multiple system atrophy.

Du JJ, Wang T, Huang P, et al.

Brain and behavior 2018; (8(12)):e01135 doi:10.1002/brb3.1135.

Non-aneurysmal Subarachnoid Hemorrhaging: A Rare Cause of Death in a Patient with Multiple System Atrophy.

Kinoshita H, Ayaki T, Maki T, et al.

Internal medicine (Tokyo, Japan) 2019; (58(11)):1643-1644 doi:10.2169/internalmedicine.1567-18.

Morphometric MRI profiles of multiple system atrophy variants and implications for differential diagnosis.

Krismer F, Seppi K, Göbel G, et al.

Movement disorders : official journal of the Movement Disorder Society 2019; (34(7)):1041-1048 doi:10.1002/mds.27669.

L-dopa response pattern in a rat model of mild striatonigral degeneration.

Kaindlstorfer C, Stefanova N, Garcia J, et al.

PloS one 2019; (14(6)):e0218130 doi:10.1371/journal.pone.0218130.

Longitudinal Change of DAT SPECT in Parkinson's Disease and Multiple System Atrophy.

Sakakibara S, Hashimoto R, Katayama T, et al.

Journal of Parkinson's disease 2020; (10(1)):123-130 doi:10.3233/JPD-191710.

Management of Orthostatic Hypotension.

Palma JA, Kaufmann H

Continuum (Minneapolis, Minn.) 2020; (26(1)):154-177 doi:10.1212/CON.0000000000000816.

Genes to treat excitotoxicity ameliorate the symptoms of the disease in mice models of multiple system atrophy.

Glat MJ, Stefanova N, Wenning GK, Offen D

Journal of neural transmission (Vienna, Austria : 1996) 2020; (127(2)):205-212 doi:10.1007/s00702-020-02158-2.

[Diagnosis of MSA-P and PSP-P in Early Stage].

Yamawaki T

Brain and nerve = Shinkei kenkyu no shinpo 2020; (72(4)):331-343 doi:10.11477/mf.1416201532.

Lower urinary tract dysfunction in common neurological diseases.

Moussa M, Papatsoris A, Chakra MA, et al.

Turkish journal of urology 2020; (46(Supp. 1)):S70-S78 doi:10.5152/tud.2020.20092.

The impact of supine hypertension on target organ damage and survival in patients with synucleinopathies and neurogenic orthostatic hypotension.

Palma JA, Redel-Traub G, Porciuncula A, et al.

Parkinsonism & related disorders 2020; (75()):97-104 doi:10.1016/j.parkreldis.2020.04.011.

Rapid Eye Movement Sleep Behavior Disorder and Other Rapid Eye Movement Parasomnias.

Howell MJ

Continuum (Minneapolis, Minn.) 2020; (26(4)):929-945 doi:10.1212/CON.0000000000000896.

In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons.

Fouka M, Mavroeidi P, Tsaka G, Xilouri M

Frontiers in cell and developmental biology 2020; (8()):559791 doi:10.3389/fcell.2020.559791.

Multiple System Atrophy - Cerebellar Type: Clinical Picture and Treatment of an Often-Overlooked Disorder.

Ortiz JF, Betté S, Tambo W, et al.

Cureus 2020; (12(9)):e10741 doi:10.7759/cureus.10741.

Viral-based rodent and nonhuman primate models of multiple system atrophy: Fidelity to the human disease.

Marmion DJ, Rutkowski AA, Chatterjee D, et al.

Neurobiology of disease 2021; (148()):105184 doi:10.1016/j.nbd.2020.105184.

Voxel-Based Meta-Analysis of Gray Matter Abnormalities in Multiple System Atrophy.

Lin J, Xu X, Hou Y, et al.

Frontiers in aging neuroscience 2020; (12()):591666 doi:10.3389/fnagi.2020.591666.

Multiple system atrophy in Hokkaido, Japan: a prospective registry study of natural history and symptom assessment scales followed for 5 years.

Matsushima M, Yabe I, Sakushima K, et al.

BMJ open 2021; (11(2)):e045100 doi:10.1136/bmjopen-2020-045100.

My Treatment Approach to Multiple System Atrophy.

Coon EA, Ahlskog JE

Mayo Clinic proceedings 2021; (96(3)):708-719 doi:10.1016/j.mayocp.2020.10.005.

Neurogenic Orthostatic Hypotension. Lessons From Synucleinopathies.

Idiaquez JF, Idiaquez J, Casar JC, Biaggioni I

American journal of hypertension 2021; (34(2)):125-133 doi:10.1093/ajh/hpaa131.

Identification of multiple system atrophy mimicking Parkinson's disease or progressive supranuclear palsy.

Miki Y, Tsushima E, Foti SC, et al.

Brain : a journal of neurology 2021; (144(4)):1138-1151 doi:10.1093/brain/awab017.

Dysphagia in multiple system atrophy consensus statement on diagnosis, prognosis and treatment.

Calandra-Buonaura G, Alfonsi E, Vignatelli L, et al.

Parkinsonism & related disorders 2021; (86()):124-132 doi:10.1016/j.parkreldis.2021.03.027.

Cardiac 18F-Dopamine PET Distinguishes PD with Orthostatic Hypotension from Parkinsonian MSA.

Lenka A, Lamotte G, Goldstein DS

Movement disorders clinical practice 2021; (8(4)):582-586 doi:10.1002/mdc3.13190.

Nocturnal stridor in multiple system atrophy: Video-polysomnography and clinical features.

Ryu HS, Kim HJ, You S, et al.

Parkinsonism & related disorders 2021; (89()):48-53 doi:10.1016/j.parkreldis.2021.03.015.

A historical review of multiple system atrophy with a critical appraisal of cellular and animal models.

Marmion DJ, Peelaerts W, Kordower JH

Journal of neural transmission (Vienna, Austria : 1996) 2021; (128(10)):1507-1527 doi:10.1007/s00702-021-02419-8.

Different phenoconversion pathways in pure autonomic failure with versus without Lewy bodies.

Goldstein DS, Isonaka R, Lamotte G, Kaufmann H

Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2021; (31(6)):677-684 doi:10.1007/s10286-021-00829-y.

Multiple System Atrophy Caregivers' Experience: A Mixed Methods Study.

Langford B, Zhou Y, Miyasaki JM

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2023; (50(1)):49-59 doi:10.1017/cjn.2021.252.

The Cold Hand Sign in Multiple System Atrophy: Frequency-Associated Factors and Its Impact on Survival.

Cao B, Liang Y, Zhang LY, et al.

Frontiers in aging neuroscience 2021; (13()):767211 doi:10.3389/fnagi.2021.767211.

Scrambler Therapy for the Treatment of Multiple System Atrophy-Parkinsonian Subtype Pain: A Case Report.

Wang EJ, Berninger LE, Pantelyat AY, et al.

A&A practice 2022; (16(1)):e01560 doi:10.1213/XAA.0000000000001560.

Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology.

Teil M, Dovero S, Bourdenx M, et al.

Brain : a journal of neurology 2022; (145(3)):1001-1017 doi:10.1093/brain/awab374.

Tracheostomy is associated with increased survival in Multiple System Atrophy patients with stridor.

Giannini G, Provini F, Cani I, et al.

European journal of neurology 2022; (29(8)):2232-2240 doi:10.1111/ene.15347.

The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy.

Wenning GK, Stankovic I, Vignatelli L, et al.

Movement disorders : official journal of the Movement Disorder Society 2022; (37(6)):1131-1148 doi:10.1002/mds.29005.

Neuropathology of Multiple System Atrophy, a Glioneuronal Degenerative Disease.

Wakabayashi K, Miki Y, Tanji K, Mori F

Cerebellum (London, England) 2024; (23(1)):2-12 doi:10.1007/s12311-022-01407-2.

Symptomatic Care in Multiple System Atrophy: State of the Art.

Grossauer A, Sidoroff V, Heim B, Seppi K

Cerebellum (London, England) 2023; (22(3)):433-446 doi:10.1007/s12311-022-01411-6.

[Dizziness upon standing: consider autonomic dysfunction].

Riksen NP, Rutten J, Bloem BR, Deinum J

Nederlands tijdschrift voor geneeskunde 2022; (166()).

A Mouse Model of Multiple System Atrophy: Bench to Bedside.

Stefanova N

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2023; (20(1)):117-126 doi:10.1007/s13311-022-01287-8.

Pervasive and diffuse muscle activity during REM sleep and non-REM sleep characterises multiple system atrophy in comparison with Parkinson's disease.

Silvani A, Baldelli L, Giannini G, et al.

Journal of sleep research 2023; (32(2)):e13721 doi:10.1111/jsr.13721.

Longitudinal evolution of motor and non-motor symptoms in early-stage multiple system atrophy: a 2-year prospective cohort study.

Zhang L, Hou Y, Cao B, et al.

BMC medicine 2022; (20(1)):446 doi:10.1186/s12916-022-02645-1.

Multiple system atrophy: α-Synuclein strains at the neuron-oligodendrocyte crossroad.

Reddy K, Dieriks BV

Molecular neurodegeneration 2022; (17(1)):77 doi:10.1186/s13024-022-00579-z.

Palliative care in Parkinson disease and related disorders.

Corcoran J, Huang AH, Miyasaki JM, Tarolli CG

Handbook of clinical neurology 2023; (191()):107-128 doi:10.1016/B978-0-12-824535-4.00017-3.

Pathological Validation of the MDS Criteria for the Diagnosis of Multiple System Atrophy.

Virameteekul S, Revesz T, Jaunmuktane Z, et al.

Movement disorders : official journal of the Movement Disorder Society 2023; (38(3)):444-452 doi:10.1002/mds.29304.

The characteristic of nonmotor symptoms with different phenotypes and onsets in multiple system atrophy patients.

Zhang J, Han J, Shi Z, et al.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2023; (109()):1-5 doi:10.1016/j.jocn.2022.12.012.

Factors impacting quality of life in multiple system atrophy.

Ali N, Nesspor V, Bang J, et al.

Frontiers in neurology 2023; (14()):1111605 doi:10.3389/fneur.2023.1111605.

Multiple system atrophy - a clinicopathological update.

Jellinger KA

Free neuropathology 2020; (1()):17 doi:10.17879/freeneuropathology-2020-2813.

Validation Study of the MDS Criteria for the Diagnosis of Multiple System Atrophy in the Mayo Clinic Brain Bank.

Sekiya H, Koga S, Murakami A, et al.

Neurology 2023; (101(24)):e2460-e2471 doi:10.1212/WNL.0000000000207905.

[The clinical application value of brain 18F-FDG PET/CT in the diagnostics of Parkinsonian syndromes].

Gu Q, Chen SF, Chen KL, et al.

Zhonghua yi xue za zhi 2023; (103(41)):3294-3300 doi:10.3760/cma.j.cn112137-20230707-01181.

Estimating the prevalence and incidence of multiple system atrophy in the USA: Insights from a national claims database.

Kaplan S, Xie H, Wang J

Parkinsonism & related disorders 2023; (117()):105920 doi:10.1016/j.parkreldis.2023.105920.

Neuropathological features of levodopa-responsive parkinsonism in multiple system atrophy: an autopsy case report and comparative neuropathological study.

Tamura M, Takeda T, Kitayama Y, et al.

Frontiers in neurology 2023; (14()):1293732 doi:10.3389/fneur.2023.1293732.

Pain in Multiple System Atrophy a Systematic Review and Meta-Analysis.

Campese N, Caliò B, Leys F, et al.

Movement disorders clinical practice 2023; (10(12)):1738-1749 doi:10.1002/mdc3.13897.

Support needs of people with Multiple System Atrophy.

Cheong JL, Goh ZH, Schrag A

Parkinsonism & related disorders 2024; (120()):106019 doi:10.1016/j.parkreldis.2024.106019.

End-of-life care in multiple system atrophy: UK survey of patients and families.

Oliver D, Barrick A, Kobylecki C, et al.

BMJ supportive & palliative care 2024; (14(e3)):e3019-e3023 doi:10.1136/spcare-2024-005045.

Early-onset dysphagia predicts short survival in multiple system atrophy.

Wada T, Shimizu T, Asano Y, et al.

Journal of neurology 2024; (271(10)):6715-6723 doi:10.1007/s00415-024-12623-7.

Deterioration of Vocal Cord Paralysis after COVID-19 Infection in Multiple System Atrophy.

Takeuchi Y, Masuda T, Kimura N, et al.

Internal medicine (Tokyo, Japan) 2024; (63(21)):2983-2986 doi:10.2169/internalmedicine.4110-24.

Immediate Effect of Continuous Positive Airway Pressure Therapy on Sleep and Respiration in Patients with Multiple System Atrophy and Sleep-Disordered Breathing.

Lazzeri G, Houot M, Patout M, et al.

Movement disorders : official journal of the Movement Disorder Society 2024; (39(11)):2026-2038 doi:10.1002/mds.29993.

Imaging Markers of Multiple System Atrophy and Their Association With Disease Severity: A Cross-Sectional Study.

Dash SK, Kamble N, Stezin A, et al.

Cureus 2024; (16(8)):e67896 doi:10.7759/cureus.67896.

A challenging case presentation of multiple system atrophy cerebellar type: A rare case report from Somalia.

Sidow NO, Ibrahim AA, Ibrahim IG, et al.

Radiology case reports 2024; (19(12)):6183-6186 doi:10.1016/j.radcr.2024.08.145.

Acute Levodopa Challenge in Atypical Parkinsonism: Comprehensive Analysis of Individual Motor Responses.

Ye L, Sani SS, Veith Sanches L, et al.

Brain sciences 2024; (14(10)) doi:10.3390/brainsci14100991.

A strategic approach of the management of sleep-disordered breathing in multiple system atrophy.

Laga A, Bauters F, Hertegonne K, et al.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2025; (21(4)):703-711 doi:10.5664/jcsm.11472.

Multiple system atrophy related neurogenic bladder: mechanism and treatment.

Ren G, Wang Y, Tian H, et al.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2025; (46(5)):1965-1976 doi:10.1007/s10072-025-08002-3.

A simple and effective screening strategy for early multiple system atrophy diagnosis and α-Synuclein forms in erythrocytes.

Jiang Y, Jin J, Piao Y, et al.

Frontiers in aging neuroscience 2025; (17()):1533504 doi:10.3389/fnagi.2025.1533504.

18 F-FDG PET/MRI in Multiple System Atrophy-Parkinsonian Type (MSA-P).

Mashriqi F, di Rocco A, Franceschi AM

Clinical nuclear medicine 2025; (50(7)):641-643 doi:10.1097/RLU.0000000000005708.

Neuropathology of Parkinson's Disease and Parkinsonism.

Dickson DW

Cold Spring Harbor perspectives in medicine 2025; doi:10.1101/cshperspect.a041610.

Late-onset multiple system atrophy: Neuropathological features associated with slow disease progression.

Ozawa M, Saito R, Konno T, et al.

Brain pathology (Zurich, Switzerland) 2025; (35(5)):e70016 doi:10.1111/bpa.70016.

MeDeMSA care study protocol: developing personalized best medical care with integrated mobile palliative and telemedicine support for individuals with multiple system atrophy.

Fanciulli A, Caliò B, Schmidt S, et al.

Journal of neural transmission (Vienna, Austria : 1996) 2025; doi:10.1007/s00702-025-02933-z.

Crosstalk between bladder-cardiovascular autonomic nervous system in synucleinopathies.

Sakakibara R, Uchiyama T, Yamamoto T

Autonomic neuroscience : basic & clinical 2025; (261()):103320 doi:10.1016/j.autneu.2025.103320.

Autonomic nervous system dysregulation in neurodegenerative diseases: Bridging brain and heart.

Singh S, Singh D, Ansari AH, Singh S

Progress in brain research 2025; (294()):47-73 doi:10.1016/bs.pbr.2025.04.010.

Multiple System Atrophy.

Xie T

Continuum (Minneapolis, Minn.) 2025; (31(4)):1000-1022 doi:10.1212/cont.0000000000001598.

Levodopa-carbidopa intestinal gel for multiple system atrophy with motor fluctuations: a case series.

Iseki T, Nishikawa N, Ogawa T, et al.

Therapeutic advances in neurological disorders 2025; (18()):17562864251360048 doi:10.1177/17562864251360048.

Clinical value of serum miR-451 in early diagnosis of multiple system atrophy from parkinson's disease and outcomes prediction.

Shi T, Jia Z

Acta neurologica Belgica 2025; doi:10.1007/s13760-025-02870-4.

Intersection of Autonomic Dysfunction and Parkinson's Disease: Insights Into Neurogenic and Classical Orthostatic Hypotension.

Pitton Rissardo J, Rashidi M, Rashidi F, et al.

Cureus 2025; (17(7)):e88487 doi:10.7759/cureus.88487.

Rapid Progression and Shorter Survival in Indians Affected with Probable MSA: A Prospective Cohort Study.

Rukmani MR, Yadav R, Bhaskarapillai B, et al.

Movement disorders clinical practice 2025; (12(12)):2113-2127 doi:10.1002/mdc3.70301.

Disease Progression in Multiple System Atrophy: The ASPIRE Multi-Modal Biomarker Study.

Fabbri M, Del Campo N, Meissner WG, et al.

Annals of neurology 2026; (99(1)):96-113 doi:10.1002/ana.70028.

Trends in Invasive Interventions and Risk Factors for Early Critical Events in Multiple System Atrophy.

Tarisawa M, Matsushima M, Kudo A, et al.

Cerebellum (London, England) 2025; (24(5)):152 doi:10.1007/s12311-025-01905-z.

Cardiovascular autonomic failure correlates with cutaneous autonomic denervation in PD and MSA.

Koay S, Provitera V, Vichayanrat E, et al.

Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2025; doi:10.1007/s10286-025-01154-4.

Stridor Is an Independent Risk Factor for Mortality and Disease Progression in Patients with Multiple System Atrophy.

Dodet P, Proust-Lima C, Sirna F, et al.

Movement disorders : official journal of the Movement Disorder Society 2026; (41(1)):120-128 doi:10.1002/mds.70080.

Rapidly Progressive Multiple System Atrophy-Cerebellar Type in a 52-Year-Old Woman: Diagnostic Challenges in a Resource-Limited Setting.

Singh KV, Nimmagadda SP, Panda A, et al.

Clinical case reports 2025; (13(12)):e71529 doi:10.1002/ccr3.71529.

An overview of the current management and emerging therapies of Multiple system atrophy.

Sorrentino C, Baldelli L, Calandra-Buonaura G, Pellecchia MT

Expert review of neurotherapeutics 2026; (26(3)):279-300 doi:10.1080/14737175.2025.2605711.

Types of Pain in Multiple System Atrophy.

Campese N, Qamar MA, Chiriac MA, et al.

Movement disorders : official journal of the Movement Disorder Society 2026; doi:10.1002/mds.70194.

Functional MRI in Multiple System Atrophy: A Promising Biomarker for Clinical Applications.

Xiao S, Ding Y, Weiss A, et al.

Neuropsychiatric disease and treatment 2026; (22()):566720 doi:10.2147/NDT.S566720.